Author:
He X,Wang Q,Cen J,Qiu H,Sun A,Chen S,Wu D
Publisher
Springer Science and Business Media LLC
Subject
Transplantation,Hematology
Reference34 articles.
1. Morishita K, Parker DS, Mucenski ML, Jenkins NA, Copeland NG, Ihle JN . Retroviral activation of a novel gene encoding a zinc finger protein in IL-3-dependent myeloid leukemia cell lines. Cell 1988; 54: 831–840.
2. Kataoka K, Sato T, Yoshimi A, Goyama S, Tsuruta T, Kobayashi H et al. Evi1 is essential for hematopoietic stem cell self-renewal, and its expression marks hematopoietic cells with long-term multilineage repopulating activity. J Exp Med 2011; 208: 2403–2416.
3. Bartholomew C, Morishita K, Askew D, Buchberg A, Jenkins NA, Copeland NG et al. Retroviral insertions in the CB-1/Fim-3 common site of integration activate expression of the Evi-1 gene. Oncogene 1989; 4: 529–534.
4. Barjesteh van Waalwijk van Doorn-Khosrovani S, Erpelinck C, van Putten WL, Valk PJ, van der Poel-van de Luytgaarde S, Hack R et al. High EVI1 expression predicts poor survival in acute myeloid leukemia: a study of 319 de novo AML patients. Blood 2003; 101: 837–845.
5. Haas K, Kundi M, Sperr WR, Esterbauer H, Ludwig WD, Ratei R et al. Expression and prognostic significance of different mRNA 5'-end variants of the oncogene EVI1 in 266 patients with de novo AML: EVI1 and MDS1/EVI1 overexpression both predict short remission duration. Genes Chromosomes Cancer 2008; 47: 288–298.
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献